OBJECTIVE . I provide researchers with tables of sample size for multiobserver receiver operating characteristic (ROC) studies that compare the diagnostic accuracies of two imaging techniques.
Sample Size Tables For Receiver Operating Characteristic Studies
OBJECTIVE . I provide researchers with tables of sample size for multiobserver receiver operating characteristic (ROC) studies that compare the diagnostic accuracies of two imaging techniques.
MATERIALS AND METHODS . I computed the number of patients and observers needed as a function of five parameters: the measure of diagnostic accuracy (area under the ROC curve, sensitivity at a false-positive rate ≤ 0.10, or specificity at a false-negative rate ≤ 0.10), conjectured level of accuracy, suspected difference in accuracy between the two imaging techniques, observer variability, and ratio of patients without to patients with the condition.
RESULTS . The numbers of patients and observers required vary dramatically with these five parameters, increasing with more refined measures of accuracy, with lower accuracy levels, with smaller suspected differences, with greater observer variability, and with less balanced designs. The number of patients required for a study can be reduced by increasing the number of observers, and vice versa. When the intra-and interobserver variability is large, a study design with just four observers is usually inadequate.
CONCLUSION . Many factors must be considered when determining the appropriate sample sizes for multiobserver ROC studies. My tables serve only as initial ballpark estimates. Investigators should compute sample size using parameters that reflect their clinical application.
any of us in radiology have been involved in designing and performing diagnostic accuracy studies, and all of us are involved in interpreting diagnostic accuracy studies. An important issue in designing these studies is determining the number of patients needed for the study. For diagnostic tests that require the interpretation of images by trained observers, a common approach is to have multiple observers interpret the images of the patients in the sample. Therefore, an additional issue is the number of observers needed for the study. I provide researchers with practical tables of sample size for such studies. My tables reveal the magnitude of patient and observer sample sizes needed and illustrate how one can trade between fewer patients and more observers or more patients and fewer observers. These tables can be used in planning your own study and can also aid in examining the adequacy of study designs of other articles.
Materials and Methods
We consider the following type of study. Suppose we want to compare the diagnostic accuracies of two imaging techniques (e.g., MR imaging and CT) for detecting a certain condition or disease (e.g., cerebral aneurysms). A sample of c patients undergo both imaging techniques. We plan for r observers to interpret all the images for the sample of c patients. That is, there are r × c × 2 interpretations. We assume that the true diagnosis is known for all patients and that the interpretations are scored in such a way that receiver operating characteristic (ROC) curves can be constructed for each observer for each imaging technique ( r x 2 ROC curves). For sample size determination, we assume that the primary focus of the research is the comparison of the average accuracy of the observers interpreting one imaging technique (e.g., MR imaging) with the average accuracy of the observers interpreting the other imaging technique (e.g., CT) to determine which imaging technique is superior. We want to determine adequate values for r and c .
A mathematic model of the relationship between the number of observers and number of patients for ROC studies has been previously proposed [1] . I used this model to prepare tables of sample size. The sample sizes were determined for a study with 5% type I error rate and 80% power. The type I error rate is the probability of wrongfully rejecting the null hypothesis (i.e., concluding that the two imaging techniques have different accuracies when, in truth, the accuracies are equal). Conversely, the power of a study is the probability of correctly rejecting the null hypothesis (i.e., concluding that the two imaging Obuchowski techniques have different accuracies when, in truth, the accuracies are different). Studies with a type I error rate of less than 5% or power of greater than 80% require larger sample sizes (larger than reported in our tables). The Appendix provides further details about the construction of the tables.
To use my tables, you must answer five questions about the study. First, what measure of diagnostic accuracy will be used to characterize the observers' performance interpreting the images? For my tables, I consider three measures of diagnostic accuracy: the area under the ROC curve, the sensitivity at a falsepositive rate less than or equal to 0.10, and the specificity at a false-negative rate less than or equal to 0.10. The area under the ROC curve is the most commonly used measure of accuracy. It is a good global measure of accuracy [2] ; however, for particular clinical applications, we are usually interested in only a certain portion of the ROC curve [3] . For example, in breast cancer screening, in which falsenegative test results have serious consequences, we demand high sensitivity; therefore, we provide sample size estimates for the specificity at a false-negative rate of less than or equal to 0.10 (sensitivity fixed at ≥ 0.90). However, for detecting asymptomatic cerebral aneurysms, when the treatment that follows positive test results (i.e., true-positives and false-positives) is very risky, we demand high specificity. For these studies, we provide sample size estimates for the sensitivity at a false-positive rate less than or equal to 0.10 (specificity ≥ 0.90).
Second, what is the conjectured accuracy of the observers with these imaging techniques? A synthesis of the relevant literature can often provide a reasonable estimate of the level of accuracy to expect. For my tables, I considered two levels of accuracy: high and moderate. For the area under the ROC curve, I set high accuracy at an area of 0.90 and moderate accuracy at 0.75. For the sensitivity at a fixed false-positive rate of less than or equal to 0.10, I define high accuracy as a sensitivity of 0.80 at a false-positive rate of 0.10 and moderate accuracy as a sensitivity of 0.60 at a false-positive rate of 0.10. Similarly, for specificity at a fixed false-negative rate of less than or equal to 0.10, I define high accuracy as a specificity of 0.80 at a false-negative rate of 0.10 and moderate accuracy as a specificity of 0.60 at a false-negative rate of 0. 10 Finally, what is the variability within (intra-) and between (inter-) the observers? Observer variability is probably dependent on many factors, including the condition of interest, the setting of image interpretations, and the heterogeneity in the observers' training and experience. The easiest way to quantify observer variability is in terms of the range of differences in accuracy. For example, if we expect that for a common set of images, observers' accuracies will differ by about 0.10 (using the area under the ROC curve, the lowest area of any observer in our sample a The anticipated difference between the accuracies of an observer who interprets the same images using the same imaging technique at two different times. b The anticipated difference between the highest accuracy of any observer in the study and the lowest accuracy of any observer in the study. Note.-Dash (-) indicates inadequate observer sample size; therefore, no patient sample size is provided. Table indicates the total number of patients (i.e., with and without the condition) required as a function of the number of observers (four, six, or 10), the variability among observers (S = small, M = moderate, or L = large), the level of accuracy of the tests (moderate accuracy = ROC area of 0.75, high accuracy = ROC area of 0.90), the suspected difference in accuracy between imaging techniques (small = 0.05, moderate = 0.10, or large = 0.15), and the ratio of patients without to patients with the condition (R = 1/1, 2/1, or 4/1). For detecting a large difference with six or 10 observers, the estimated number of patients is small. I believe that a reasonable minimum is 10 each of patients with and without the condition; therefore, I have set the data accordingly. a 80% power, 5% type I error, two-tailed test. 
Results
Tables 2-4 summarize the total number of patients required for studies that use the three measures of accuracy: the area under the ROC curve (Table 2) , the sensitivity at a false-positive rate of less than or equal to 0.10 (Table 3) , and the specificity at a false-negative rate of less than or equal to 0.10 (Table 4) . Tables 2-4 reveal how the sample size requirements are larger when researchers are interested in a focused portion of the ROC curve (sensitivity or specificity for a fixed false-positive range or false-negative range) rather than the entire ROC curve. Between six and nine times more patients are required for these studies. However, we should not allow these increased sample size requirements to detract from the more refined measures of diagnostic accuracy. Also note that the required patient sample size decreases as the number of observers increases, as the observer variability decreases, as the accuracy increases, as the suspected difference increases, or as the ratio of patients without to patients with the condition approaches 1:1 (balanced design).
In the following text, I illustrate the use of my tables with two examples. First, suppose we are designing a study to compare the accuracies of MR imaging and CT for the detection of cerebral aneurysms, and we choose as our measure of accuracy the sensitivity at a falsepositive rate of less than or equal to 0.10. We anticipate the two imaging techniques to have high accuracy (sensitivities near 0.80 at a false-positive rate of 0.10). We would like to be able to detect a difference in sensitivities of 0.10 or more at a false-positive rate of 0.10. We anticipate that there will be four times more patients without an aneurysm than with an aneurysm in our sample, and we expect large observer variability (sensitivities of all the observers at a false-positive rate of 0.10 may differ by as much as 0.10; and the sensitivities at a false-positive rate of 0.10 by a single observer on two different interpreting occasions may differ by as much as 0.05). Referring to Table 3 , a study design with 353 patients (71 with an aneurysm and 282 without) and six observers or 123 patients (25 with an aneurysm and 98 without) and 10 observers would be adequate. Note that a study design with only four observers would be inadequate for this example because of the expected large observer variability.
For my second example, suppose we use the tables as an aid to evaluate the adequacy of the sample sizes of an article. Consider the study by Powell et al. [5] that compared the diagnostic accuracies of film-screen radiography and digitized mammograms. (Note that Powell et al. were testing if the two display modes were equivalent, not if one was superior; the statistics are different, but we can still use this study as an example.) Seven observers interpreted 60 cases using both display formats. The study included 30 patients with at least one malignant lesion and 30 patients without a malignant lesion. Each breast was divided into five regions, and each region of each breast was interpreted by the observers. One of the measurements of accuracy was the area under the ROC curve. The average area under the ROC curve of the seven observers was 0.86. The range of areas under the ROC curve for the seven observers was 0.107 (0.827-0.934) for film and 0.098 (0.792-0.890) for digitized images. Five observers interpreted the images in two separate
Note.-Dash (-) indicates inadequate observer sample size; therefore, no patient sample size is provided. Table indicates the total number of patients (i.e., with and without the condition) required as a function of the number of observers (four, six, or10), the variability among observers (S = small, M = moderate, or L = large), the level of accuracy of the tests (moderate accuracy = sensitivity of 0.60 at a false-positive rate of 0.10, high accuracy = sensitivity of 0.80 at a false-positive rate of 0.10), the suspected difference in sensitivities between the imaging techniques at a false-positive rate of 0.10 (small = 0.05, moderate = 0.10, or large = 0.15), and the ratio (1/1, 2/1, or 4/1) of patients without to patients with the condition. a 80% power, 5% type I error, two-tailed test. Obuchowski interpreting sessions. The average range of the difference in the areas under the ROC curve from these two interpretations was 0.05 (the absolute values of the differences for the five observers were 0.072, 0.047, 0.089, 0.011, and 0.029). Refer to Table 2 for the area under the ROC curve and look under high accuracy (because the average area under the ROC curve was nearly 0.90) and large observer variability (because the inter-and intraobserver variabilities were 0.10 and 0.05, respectively). Our particular observer sample size of seven is not included in the table; nor is the situation of multiple regions from the same patient considered in the table. However, we can interpolate that a moderate to large difference in the areas under the ROC curve can be detected with this study design.
Discussion
I presented tables of sample size to provide investigators with a sense of the sample sizes needed for ROC studies and to illustrate the trade-off between the number of patients and the number of observers that can be used for these studies. My tables should serve only as initial ballpark estimates of the sample sizes required for any study. It is important that investigators compute sample size using parameters that reflect their clinical application. For example, investigators should consider the values of sensitivity (or specificity) that they expect (not just the two values I considered), and they should use the false-positive rate or falsenegative rate ranges appropriate to their clinical application. Furthermore, investigators should assess the applicability of the assumptions I made. For example, I assumed that the test results from the two imaging techniques were correlated, with a correlation of 0.47. This value is the average correlation reported by Rockette et al. [4] from 20 multiobserver ROC studies. However, if different samples of patients underwent the two different types of imaging, then the correlation would be zero. In this case, the sample sizes reported represent a considerable underestimation of the required sample size.
Other study design issues also affect sample size. For example, in many applications, there is more than one unit per patient; for example, five regions from each of two breasts in evaluating screening mammography [5] , or situations with the possibility of two or more lesions in the same patient. These units from the same patient are not statistically independent and cannot be analyzed as independent observations. My tables of sample size assume one unit per patient. When there are multiple units per patient, the sample sizes I presented will usually be an overestimation of the number of patients required. However, it would not be appropriate to assume that the number of units needed is equivalent to the number of patients estimated in my tables; this strategy would result in a study with inadequate power.
Another issue to consider in sample size estimation is the plan for subgroup analyses. Often, investigators want to report accuracy and the comparative accuracies of the two imaging techniques for particular subgroups (subgroups categorized by gender, age, or symptoms). For these analyses, sample sizes larger than those reported here are generally required.
My study of sample size for multiobserver ROC studies has several limitations. First, the sample sizes are derived from one mathematic model [1] of the relationship among accuracy, observer variability, patient variability, and the correlation in accuracy imposed by study design. Other more sophisticated models exist [6, 7] , but no associated algorithms are available for calculating sample size. A study by Rockette et al. [4] suggested that for sample size estimation, the simpler model used here is adequate. Second, for simplicity, we made several assumptions about the distributions of the unobserved test results (i.e., binormality with equal variances) (Appendix). These assumptions may not be applicable for all studies; therefore, I encourage readers to assess these assumptions for their particular studies. Finally, I have focused on only one issue of study design: sample size. It is important to recognize that an adequate sample size cannot Note.-Dash (-) indicates inadequate observer sample size; therefore, no patient sample size is provided. Table indicates the total number of patients (i.e., with and without the condition) required as a function of the number of observers (four, six, or 10), the variability among observers (S = small, M = moderate, or L = large), the level of accuracy of the tests (moderate accuracy = specificity of 0.60 at a false-negative rate of 0.10, high accuracy = specificity of 0.80 at a false-negative rate of 0.10), the suspected difference in specificities between the imaging techniques at a false-negative rate of 0.10 (small = 0.05, moderate = 0.10, and large = 0.15), and the ratio (1/1, 2/1, or 4/1) of patients without to patients with the condition. a 80% power, 5% type I error, two-tailed test. compensate for systematic biases that are common in our literature [8] [9] [10] [11] [12] [13] . Therefore, it is critical that we sample patients and observers carefully for our studies, that we identify and apply appropriate procedures for determining the true diagnoses, and that images are interpreted in a blinded fashion.
Obuchowski
It is assumed that the null and alternative hypotheses of primary interest are
where u i is the mean diagnostic accuracy of imaging technique i for the population of observers. For sample size estimation, under the alternative hypothesis we specify that u 1 -u 2 = ∆ , where ∆ is the suspected difference. Obuchowski and Rockette [14] proposed a modified F statistic to test the null hypothesis in equation 1. The noncentrality parameter of the F statistic, denoted λ , can be used to derive sample size estimates [1] . The parameter λ is a function of three variances, four correlations, the number of observers (indicated by J ), and ∆ ,
where σ 2 b is the variability in observers' accuracies when using the same imaging technique for the same sample of patients (interobserver variability), σ 2 w is the variability in a single observer's accuracies when using the same imaging technique for the same sample of patients on different interpreting occasions (intraobserver variability), σ 2 c is the variability between samples of patients and is a function of the number of patients in the sample, r 1 is the correlation between accuracies estimated from the same sample of patients by the same observer using different imaging techniques, r 2 is the correlation between accuracies estimated from the same sample of patients by different observers using the same imaging technique, r 3 is the correlation between accuracies estimated from the same sample of patients by different observers using different imaging techniques, r b is the correlation between accuracies obtained when a set of observers examines the same sample of patients using different diagnostic tests, and K is the number of times each observer interprets the same images from the same imaging technique.
For the tables in this paper, I used three different levels of σ 2 b and σ 2 w . I estimated σ 2 b and σ 2 w from the ranges in Table 1 by assuming that observers' accuracies follow a normal distribution. Note that these variances and correlations were estimated by Rockette et al. [4] for the area under the ROC curve and not for the partial area under the ROC curve. For my tables, I assumed that these variances and correlation values are also reasonable when the partial area under the ROC curve is used.
For different values of J, I used the function PROBF in SAS software (SAS Institute, Cary, NC) to determine the value of the noncentrality parameter that would provide 80% power with a 5% type I error rate. These values of λ are 18.12, 12.36, and 9.92, for J equal to 4, 6, and 10, respectively. I substituted the above values of σ 2 b , σ 2 w , r 1 , r 2 , r 3 , and r b into equation 2. Then for the different combinations of J and ∆, I solved for σ 2 c . The value of σ 2 c , when positive, represents the maximum patient variance permitted for the study design. Because σ 2 c is a function of the number of patients, I was able to calculate the number of patients needed for each combination of J and ∆. When the estimate of σ 2 c was negative or almost zero, I concluded that the number of observers was inadequate for the study design.
For the area under the ROC curve summary measure, an estimate of σ 2 c for sample size estimation is [16] 
where A = Φ -1 (θ) × 1.414, and θ is the anticipated area under the ROC curve, Φ -1 is the inverse of the cumulative normal distribution function, R is the ratio of sample sizes of patients without the condition to with the condition, and N is the number of patients with the condition. Substituting into equation 3 the anticipated value of the area under the ROC curve (0.75 or 0.90), the value of R (1.0, 2.0, or 4.0), and the maximum patient variance calculated from equation 2, the number of patients needed with the condition can be determined. Then the total patient sample size needed is N (1 + R). For the partial area under the ROC curve in the false-positive rate range from 0.0 to 0.10 (or for the partial area under the ROC curve in the falsenegative rate range from 0.0 to 0.10), we first need to convert the values of ∆ and the values for the interobserver and intraobserver ranges given in Table 1 into values for the partial area under the ROC curve. (Note that these values have been defined in terms of the sensitivity [specificity] at a false-positive rate [false-negative rate] of 0.10.) To do this we need to specify an ROC curve among all possible ROC curves that pass through the point (false-positive rate = 0.10; sensitivity = 0.60 [or 0.80]). We assume that the test results of patients with and without the condition follow a binormal distribution with equal variance (binormal parameter b = 1.0). Therefore, for sensitivities of 0.60 and 0.80 at a false-positive rate of 0.10, the corresponding binormal parameter a's (the standardized difference in the means of the two distributions) are 1.535 and 2.120, and the corresponding partial areas under the curves are 0.0424 and 0.0637, respectively. For a suspected difference between the two imaging techniques of 0.05 (in terms of sensitivity at a false-positive rate of 0.10), we can define two ROC curves with parameter a's of 1.47 and 1.60, which correspond to sensitivities of 0.575 and 0.625 and partial areas of 0.0400 and 0.0447, respectively. Therefore, I translated a difference of 0.05 in terms of sensitivities at a false-positive rate of 0.10 into a difference in terms of the partial areas of 0.0047. I performed this transformation for each of the values of ∆ and the values for the interobserver and intraobserver ranges given in Table 1 . I used these transformed values in equation 2 to determine the maximum patient variance for each study design.
Then an estimate of σ 2 c for the partial areas used for sample-size estimation is [17] (4) where a and b are parameters from a binormal distribution, R and N are the same as in equation 3, and f and g are functions of the binormal parameters and the range of false-positive rates of interest [17] . I set b = 1 and a = 1.535 or 2.120, corresponding to sensitivities of 0.6 and 0.8 at a false-positive rate of 0. 
